TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
AQST

Aquestive Therapeutics Inc

Healthcare · Drug Manufacturers - Specialty & Generic

4.80$ +3.7% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

Aquestive Therapeutics Inc (AQST) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 160 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AQST
Line item 2005 2006 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
12 27 39 43 87 78 63 62 57 57 101 160
2.3 17 23 28 74 68 45 47 40 41 88 149
1.3 15 9.2 17 61 49 32 28 27 24 72 121
15 9.2 17 61 49 32 28 27 24 72 121
0.2 0.8 11 6.2 6.5 13 7.0 12 4.7 8.5 7.3 18
0.7 0.5 2.9 4.0 5.4 2.9 2.5 4.0 5.8 6.8 6.0 6.2
7.6 8.6 15 13 12 9.7 6.9 5.1 7.9
0.3
1.9 1.7 0.3 0.3 0.2 0.2 0.1 0.1 1.4 1.3
7.6 1.9 57 70 77 85 111 144 176 164 162 194
1.7 1.8 11 15 33 19 21 22 40 18 19 48
0.3 39 0.3 4.6 3.3 2.9 19 0.4 0.5 12
1.2 1.1 6.6 9.6 20 12 7.1 8.3 9.9 8.9 10 30
5.9 39 46 43 60 34 52 33 28 33 28
4.7 25 -18 -26 10 -6.1 -48 -82 -119 -106 -60 -34
-12 -25 -109 -120 -61 -130 -186 -257 -311 -319 -363 -447
25 20 21 25 34 38 49 61 87 122

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?